The IL-4 receptor: signaling mechanisms and biologic functions.
暂无分享,去创建一个
W. Paul | J. Ryan | J. Zamorano | A. Keegan | K. Nelms | W E Paul | K Nelms | A D Keegan | J Zamorano | J J Ryan
[1] W. Sebald,et al. The interleukin‐4 site‐2 epitope determining binding of the common receptor γ chain , 1998 .
[2] W. Paul,et al. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. , 1998, Journal of immunology.
[3] J. Zamorano,et al. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. , 1998, Journal of immunology.
[4] W. Paul,et al. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. , 1998, Immunity.
[5] J. Stavnezer,et al. Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.
[6] P. Pereira,et al. Requirement for γδ T Cells in Allergic Airway Inflammation , 1998 .
[7] R. Puri,et al. Interleukin-13 Receptor α′ But Not α Chain: A Functional Component of Interleukin-4 Receptors , 1998 .
[8] M. Gadina,et al. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. , 1998, Journal of immunology.
[9] W. Paul,et al. Impaired Interleukin 4 Signaling in T Helper Type 1 Cells , 1998, The Journal of experimental medicine.
[10] J. Zamorano,et al. A Role for the Insulin-Interleukin (IL)-4 Receptor Motif of the IL-4 Receptor α-Chain in Regulating Activation of the Insulin Receptor Substrate 2 and Signal Transducer and Activator of Transcription 6 Pathways , 1998, The Journal of Biological Chemistry.
[11] M. Kaplan,et al. Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression , 1998, Molecular and Cellular Biology.
[12] P. Marrack,et al. Cytokine-induced survival of activated T cells in vitro and in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Shoelson,et al. Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.
[14] F. Finkelman,et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. , 1998, Immunity.
[15] P. Pandolfi,et al. Molecular Cloning and Characterization of p56 dok-2 Defines a New Family of RasGAP-binding Proteins* , 1998, The Journal of Biological Chemistry.
[16] J. Pierce,et al. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] Y. Yazaki,et al. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway. , 1998, Blood.
[18] N. Hamasaki,et al. Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma , 1998, Nature Genetics.
[19] T. Chatila,et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.
[20] L. Steinman,et al. CD4+ T-cell subsets in autoimmunity. , 1997, Current opinion in immunology.
[21] D. Leroith,et al. A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.
[22] M. Boothby,et al. HMG-I(Y) Phosphorylation Status as a Nuclear Target Regulated through Insulin Receptor Substrate-1 and the I4R Motif of the Interleukin-4 Receptor* , 1997, The Journal of Biological Chemistry.
[23] G. Freeman,et al. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. , 1997, Science.
[24] W. Paul,et al. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] I. Kerr,et al. Janus Kinase-dependent Activation of Insulin Receptor Substrate 1 in Response to Interleukin-4, Oncostatin M, and the Interferons* , 1997, The Journal of Biological Chemistry.
[26] J. Darnell. STATs and gene regulation. , 1997, Science.
[27] W. Paul,et al. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. , 1997, Journal of immunology.
[28] G. Lienhard,et al. A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.
[29] G. Stark,et al. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Dantzer,et al. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. , 1997, Journal of immunology.
[31] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[32] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[33] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[34] B. Nelson,et al. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. , 1997, Journal of immunology.
[35] A. Toker,et al. Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.
[36] H. Fujiwara,et al. Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Manning,et al. Interleukin-4 Suppression of Tumor Necrosis Factor α-stimulated E-selectin Gene Transcription Is Mediated by STAT6 Antagonism of NF-κB* , 1997, The Journal of Biological Chemistry.
[38] B. Brown,et al. A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. , 1997, Biochemical and biophysical research communications.
[39] B. Čatipović,et al. Interleukin-4 (IL-4) Induces Phosphatidylinositol 3-Kinase (p85) Dephosphorylation , 1997, The Journal of Biological Chemistry.
[40] R. Flavell,et al. Jak1 Expression Is Required for Mediating Interleukin-4-induced Tyrosine Phosphorylation of Insulin Receptor Substrate and Stat6 Signaling Molecules* , 1997, The Journal of Biological Chemistry.
[41] Lewis C Cantley,et al. PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.
[42] W. Paul,et al. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells. , 1997, Journal of immunology.
[43] N. Copeland,et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. , 1997, Molecular endocrinology.
[44] David R. Kaplan,et al. Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.
[45] D. Baltimore,et al. Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok , 1997, Cell.
[46] R. Kobayashi,et al. p62 dok : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells , 1997, Cell.
[47] P. Ferrara,et al. Cloning of the human IL‐13Rα1 chain and reconstitution with the IL‐4Rα of a functional IL‐4/IL‐13 receptor complex , 1997 .
[48] R. Puri,et al. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. , 1997, Journal of immunology.
[49] S. Akira,et al. NF-IL6 and NF-kappa B in cytokine gene regulation. , 1997, Advances in immunology.
[50] J. Kinet,et al. The Emerging Field of Receptor-Mediated Inhibitory Signaling: SHP or SHIP? , 1996, Cell.
[51] J. Cambier,et al. The SHIP phosphatase becomes associated with Fc gammaRIIB1 and is tyrosine phosphorylated during 'negative' signaling. , 1996, Immunology letters.
[52] Ling-mei Wang,et al. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. , 1996, Journal of immunology.
[53] R. Puri,et al. cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain* , 1996, The Journal of Biological Chemistry.
[54] K. Izuhara,et al. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. , 1996, Blood.
[55] G. Krystal,et al. Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. , 1996, Blood.
[56] U. Schindler,et al. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6 , 1996, Molecular and cellular biology.
[57] B. Groner,et al. Homodimerization of Interleukin-4 Receptor α Chain Can Induce Intracellular Signaling* , 1996, The Journal of Biological Chemistry.
[58] H. Band,et al. A Novel Phosphotyrosine-binding Domain in the N-terminal Transforming Region of Cbl Interacts Directly and Selectively with ZAP-70 in T Cells* , 1996, The Journal of Biological Chemistry.
[59] D T Denhardt,et al. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.
[60] M. Goldsmith,et al. Interleukin‐4‐specific signal transduction events are driven by homotypic interactions of the interleukin‐4 receptor alpha subunit. , 1996, The EMBO journal.
[61] Enrico A. Stura,et al. Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.
[62] V. Band,et al. Tyrosine Phosphorylation of Cbl upon Epidermal Growth Factor (EGF) Stimulation and Its Association with EGF Receptor and Downstream Signaling Proteins* , 1996, The Journal of Biological Chemistry.
[63] S. Shoelson,et al. Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor , 1996, Cell.
[64] W. Paul,et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.
[65] S. Akira,et al. Essential role of Stat6 in IL-4 signalling , 1996, Nature.
[66] R. Puri,et al. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. , 1996, Journal of immunology.
[67] J. Bertoglio,et al. Interleukin-4 Induces Activation of Mitogen-activated Protein Kinase and Phosphorylation of Shc in Human Keratinocytes (*) , 1996, The Journal of Biological Chemistry.
[68] R. Meadows,et al. Structural basis for IL-4 receptor phosphopeptide recognition by thelRS-1 PTB domain , 1996, Nature Structural Biology.
[69] M. Kaplan,et al. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.
[70] P. Majerus,et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[71] S. Shoelson,et al. p120 Is a Major Substrate of Tyrosine Phosphorylation upon B Cell Antigen Receptor Stimulation and Interacts in Vivo with Fyn and Syk Tyrosine Kinases, Grb2 and Shc Adaptors, and the p85 Subunit of Phosphatidylinositol 3-Kinase (*) , 1996, The Journal of Biological Chemistry.
[72] J. Ihle. STATs: Signal Transducers and Activators of Transcription , 1996, Cell.
[73] W. Paul,et al. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. , 1996, Immunity.
[74] W. Paul,et al. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. , 1996, Immunity.
[75] A. DeFranco,et al. Activation-induced Association of a 145-kDa Tyrosine-phosphorylated Protein with Shc and Syk in B Lymphocytes and Macrophages (*) , 1996, The Journal of Biological Chemistry.
[76] J. G. Zhang,et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[77] Eric O Long,et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.
[78] C. Marshall,et al. Control of the ERK MAP kinase cascade by Ras and Raf. , 1996, Cancer surveys.
[79] J. Downward,et al. Control of ras activation. , 1996, Cancer surveys.
[80] Dwight C. Look,et al. Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.
[81] A. Petros,et al. Structure and ligand recognition of the phosphotyrosine binding domain of Shc , 1995, Nature.
[82] J. Johnston,et al. Interleukins 2, 4, 7, and 15 Stimulate Tyrosine Phosphorylation of Insulin Receptor Substrates 1 and 2 in T Cells POTENTIAL ROLE OF JAK KINASES (*) , 1995, The Journal of Biological Chemistry.
[83] Roger J. Davis,et al. Transcriptional regulation by MAP kinases , 1995, Molecular reproduction and development.
[84] S Goelz,et al. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1 , 1995, Molecular and cellular biology.
[85] M. White,et al. PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) , 1995, The Journal of Biological Chemistry.
[86] P. Sigler,et al. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[87] W. Fridman,et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. , 1995, Immunity.
[88] L. Sanders,et al. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[89] E. Petricoin,et al. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.
[90] William Arbuthnot Sir Lane,et al. Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.
[91] G. Lienhard,et al. Interleukin-9 Induces Tyrosine Phosphorylation of Insulin Receptor Substrate-1 via JAK Tyrosine Kinases (*) , 1995, The Journal of Biological Chemistry.
[92] J. Stavnezer,et al. Regulation of Antibody Class Switching to IgE: Characterization of an IL‐4‐Responsive Region in the Immunoglobulin Heavy‐Chain Germline ε Promoter a , 1995, Annals of the New York Academy of Sciences.
[93] S. Shoelson,et al. The SH3 Domain-binding T Cell Tyrosyl Phosphoprotein p120 , 1995, The Journal of Biological Chemistry.
[94] S. Shoelson,et al. Specificity of the PTB Domain of Shc for β Turn-forming Pentapeptide Motifs Amino-terminal to Phosphotyrosine (*) , 1995, The Journal of Biological Chemistry.
[95] J. Darnell,et al. Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.
[96] I. Pastan,et al. A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4 (*) , 1995, The Journal of Biological Chemistry.
[97] C. Thompson,et al. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[98] S. McKnight,et al. Components of a Stat recognition code: evidence for two layers of molecular selectivity. , 1995, Immunity.
[99] M. Welham,et al. Interleukin-13 Signal Transduction in Lymphohemopoietic Cells , 1995, The Journal of Biological Chemistry.
[100] A. Craparo,et al. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.
[101] J. Chung,et al. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. , 1995, Journal of Immunology.
[102] T. Taniguchi. Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.
[103] K. Siminovitch,et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. , 1995, Science.
[104] R. Puri,et al. Receptor for Interleukin 13 , 1995, The Journal of Biological Chemistry.
[105] T. Blankenstein,et al. The rat interleukin 4 receptor: coevolution of ligand and receptor. , 1995, Cytokine.
[106] J. Blenis,et al. Requirement of serine phosphorylation for formation of STAT-promoter complexes. , 1995, Science.
[107] E. Skolnik,et al. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin , 1995, Molecular and cellular biology.
[108] R. Reeves,et al. The non‐histone chromosomal protein HMG‐I(Y) contributes to repression of the immunoglobulin heavy chain germ‐line ε RNA promoter , 1995, European journal of immunology.
[109] Tony Pawson,et al. Protein modules and signalling networks , 1995, Nature.
[110] T. Pawson. Getting down to specifics , 1995, Nature.
[111] M. Schrenzel,et al. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo , 1995, Nature.
[112] A. Duschl,et al. Both Interleukin 4 and Interleukin 13 Induce Tyrosine Phosphorylation of the 140-kDa Subunit of the Interleukin 4 Receptor (*) , 1995, The Journal of Biological Chemistry.
[113] J. Stavnezer,et al. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF- IL-4, a C/EBP family member and NF-kappa B/p50 , 1995, The Journal of experimental medicine.
[114] J. Ihle. The Janus protein tyrosine kinase family and its role in cytokine signaling. , 1995, Advances in immunology.
[115] L. Williams,et al. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. , 1994, Science.
[116] O. Silvennoinen,et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.
[117] J. Johnston,et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.
[118] T. O’Neill,et al. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.
[119] T Pawson,et al. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. , 1994, Oncogene.
[120] S. McKnight,et al. An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.
[121] D. Bowtell,et al. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. , 1994, The Journal of biological chemistry.
[122] N. Ruderman,et al. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. , 1994, The Journal of biological chemistry.
[123] L. Cantley,et al. Phosphatidylinositol 3‐kinase , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.
[124] K. Izuhara,et al. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. , 1994, The Journal of biological chemistry.
[125] E. Liu,et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells , 1994, Nature.
[126] J. Johnston,et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2 , 1994, Nature.
[127] M. Nussenzweig,et al. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling , 1994, Nature.
[128] W. Paul,et al. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 , 1994, The Journal of experimental medicine.
[129] P. Leder,et al. Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[130] W. Paul,et al. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth , 1994, Cell.
[131] M. Nussenzweig,et al. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling , 1994, Nature.
[132] V. Duronio,et al. Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth. , 1994, The Journal of biological chemistry.
[133] I Gout,et al. PI 3‐kinase is a dual specificity enzyme: autoregulation by an intrinsic protein‐serine kinase activity. , 1994, The EMBO journal.
[134] J. Tavernier,et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.
[135] M. Kasuga,et al. PI 3‐kinase: structural and functional analysis of intersubunit interactions. , 1994, The EMBO journal.
[136] L. Cantley,et al. Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.
[137] W. Paul,et al. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.
[138] W. Leonard,et al. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). , 1994, Advances in experimental medicine and biology.
[139] S. Ziegler,et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.
[140] K. Arai,et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.
[141] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[142] M. White,et al. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.
[143] G. Stark,et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.
[144] P. Hawkins,et al. Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system? , 1993, Biochimica et biophysica acta.
[145] M. White,et al. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.
[146] R. Ashman,et al. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. , 1993, Journal of immunology.
[147] A. Klippel,et al. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. , 1993, Molecular and cellular biology.
[148] D. Beier,et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.
[149] T. Pawson,et al. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.
[150] M. Wigler,et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. , 1993, Science.
[151] G. Lienhard,et al. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[152] F. Kalthoff,et al. Human interleukin‐4 receptor signaling requires sequences contained within two cytoplasmic regions , 1993, European journal of immunology.
[153] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[154] R. Perlmutter,et al. Association of p56lck with IL‐2 receptor beta chain is critical for the IL‐2‐induced activation of p56lck. , 1993, The EMBO journal.
[155] Sheila M. Thomas,et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.
[156] J. Gutkind,et al. IL‐4 activates a distinct signal transduction cascade from IL‐3 in factor‐dependent myeloid cells. , 1992, The EMBO journal.
[157] G. Delespesse,et al. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression , 1992, The Journal of experimental medicine.
[158] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[159] M. Fellous,et al. A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.
[160] C. Hsieh,et al. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[161] V. Duronio,et al. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[162] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[163] K. Yasukawa,et al. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[164] K. Clauser,et al. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.
[165] K. Rajewsky,et al. Generation and analysis of interleukin-4 deficient mice. , 1991, Science.
[166] C. Kahn,et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.
[167] H. Gascan,et al. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones , 1991, The Journal of experimental medicine.
[168] J. Lanchbury,et al. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. , 1991, Journal of immunology.
[169] J. Banchereau,et al. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. , 1990, International immunology.
[170] Alan I. Alpert,et al. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.
[171] P. Libby,et al. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.
[172] W. Paul,et al. Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[173] A. Ullrich,et al. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.
[174] W. Paul,et al. Interleukin 4 induces membrane Thy-1 expression on normal murine B cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[175] J. Lowenthal,et al. Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. , 1988, Journal of immunology.
[176] F. McCormick,et al. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.
[177] K. Arai,et al. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes , 1987, The Journal of experimental medicine.
[178] W. Paul,et al. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage , 1987, Nature.
[179] E. Shevach,et al. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes , 1987, The Journal of experimental medicine.
[180] R. Coffman,et al. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. , 1986, Journal of immunology.
[181] W. Paul,et al. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1 , 1985, The Journal of experimental medicine.
[182] J. Uhr,et al. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[183] W. Paul,et al. Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.
[184] R. Huebner,et al. Genetic control by the hr-locus of susceptibility and resistance to leukemia. , 1969, Proceedings of the National Academy of Sciences of the United States of America.